Sharda Cropchem Ltd
Sharda Cropchem Ltd
CommoditiesKey Fundamentals
MicrocapPesticides & AgrochemicalsChemicalsInsights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Sharda Cropchem Ltd insights
42 extracted metrics + investor summaries across FY15–FY26.
Tapetide Score
Data-driven rating, 0–100. How it works →
Technical Indicators
Key Insights
Strengths
4- Company has reduced debt.
- Company is almost debt free.
- Company has delivered good profit growth of 23.8% CAGR over last 5 years
- Company has been maintaining a healthy dividend payout of 43.8%
Weaknesses
2- Company has a low return on equity of 13.2% over last 3 years.
- Company has high debtors of 166 days.
Growth Rate
AI Analysis — Bull vs Bear
Sharda Cropchem Ltd trades at a market cap of ₹8,345 Cr with a PE of 12.1x and has delivered TTM profit growth of 128% while remaining virtually debt-free. However, the company carries high debtor days of 166 and a 3-year average ROE of only 13.6%, reflecting working capital intensity in its asset-light agrochemical distribution model.
- TTM profit growth of 128% signals a sharp earnings recovery, with 5-year compounded profit CAGR at 25%
- Company is almost debt-free, reducing financial risk and interest burden significantly
- PE of 12.1x is modest relative to 5-year profit CAGR of 25%, implying earnings are not yet fully priced in
- Healthy dividend payout of 43.8% demonstrates shareholder-friendly capital allocation with 0.66% current yield
- Last year ROE jumped to 24%, well above the 3-year average of 14%, indicating improving capital efficiency
- Compounded sales CAGR of 17% over 5 years and 16% over 10 years shows consistent top-line growth trajectory
- Stock CAGR of 20% over 5 years and 19% over 3 years reflects sustained wealth creation for long-term holders
- Asset-light model with global registrations across 80+ countries provides a wide distribution moat with low capex needs
- High debtor days of 166 indicate significant working capital blockage and potential collection risk
- 3-year average ROE of only 13.6% is below par for a debt-free company, suggesting sub-optimal capital utilization
- 1-year stock CAGR of -1% shows the market has not rewarded recent earnings growth, signaling possible skepticism about sustainability
- Revenue is largely dependent on agrochemical commodity cycles with TTM sales growth of 22% potentially reflecting cyclical tailwinds rather than structural gains
- PB ratio of 2.62x for a company with 3-year ROE of only 14% implies limited margin of safety on book value basis
- Dividend yield of just 0.66% despite 43.8% payout ratio means absolute income generation for investors remains low
- 10-year stock CAGR of only 9% lags the broader market returns, suggesting long-term compounding has been inconsistent
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
- Record date for FY26 dividend Jul 02
Sharda Cropchem fixed August 7, 2026 as the record date for its final dividend for FY26. The AGM is scheduled for August 14, 2026.
TL;DR: Limited recent news flow for Sharda Cropchem. The company has announced routine corporate actions with a record date for its FY26 final dividend set for August 7. No material headwinds or positive catalysts are visible from current news, leaving the near-term outlook dependent on upcoming quarterly results and agrochemical demand trends.
Quarterly Results
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 638 | 581 | 632 | 1,312 | 785 | 777 | 929 | 1,829 | 985 | 929 | 1,289 | 2,065 | 1,074 |
| Expenses | 697 | 560 | 563 | 1,057 | 708 | 687 | 815 | 1,525 | 770 | 796 | 1,048 | 1,578 | 888 |
| Operating Profit | -59 | 21 | 69 | 255 | 77 | 90 | 115 | 303 | 215 | 133 | 241 | 487 | 186 |
| OPM % | -9% | 3.6% | 11% | 19% | 10% | 12% | 12% | 17% | 22% | 14% | 19% | 24% | 17% |
| Other Income | 26 | 24 | 12 | -2 | 19 | 25 | 1 | 25 | 32 | 29 | 21 | 22 | 35 |
| Interest | 1 | 5 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 2 |
| Depreciation | 70 | 74 | 69 | 54 | 65 | 69 | 69 | 72 | 78 | 76 | 83 | 87 | 100 |
| PBT | -105 | -34 | 12 | 198 | 31 | 46 | 46 | 256 | 169 | 86 | 179 | 422 | 118 |
| Tax % | -15% | -18% | 62% | 28% | 11% | 7% | 32% | 20% | 16% | 13% | 19% | 24% | 26% |
| Net Profit | -89 | -28 | 5 | 143 | 27 | 42 | 31 | 204 | 143 | 74 | 145 | 319 | 88 |
| EPS in Rs | -9.82 | -3.06 | 0.51 | 15.9 | 3.02 | 4.7 | 3.45 | 22.56 | 15.83 | 8.24 | 16.09 | 35.32 | 9.76 |
Profit & Loss
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,061 | 1,222 | 1,399 | 1,707 | 1,998 | 2,003 | 2,396 | 3,580 | 4,045 | 3,163 | 4,320 | 5,268 | 5,357 |
| Expenses | 878 | 941 | 1,075 | 1,343 | 1,621 | 1,653 | 1,945 | 2,884 | 3,386 | 2,860 | 3,705 | 4,209 | 4,310 |
| Operating Profit | 183 | 281 | 324 | 364 | 376 | 350 | 450 | 696 | 659 | 303 | 615 | 1,059 | 1,047 |
| OPM % | 17% | 23% | 23% | 21% | 19% | 17% | 19% | 19% | 16% | 10% | 14% | 20% | 20% |
| Other Income | 25 | 23 | 14 | 9 | -22 | -12 | 46 | 29 | 40 | 60 | 60 | 142 | 108 |
| Interest | 9 | 8 | 9 | 15 | 20 | 16 | 16 | 15 | 20 | 24 | 21 | 21 | 3 |
| Depreciation | 23 | 35 | 56 | 70 | 99 | 137 | 170 | 245 | 248 | 267 | 275 | 325 | 347 |
| PBT | 175 | 261 | 272 | 287 | 235 | 185 | 309 | 464 | 431 | 72 | 378 | 856 | 805 |
| Tax % | 30% | 33% | 30% | 34% | 25% | 11% | 26% | 25% | 21% | 56% | 20% | 20% | — |
| Net Profit | 123 | 175 | 190 | 191 | 176 | 165 | 229 | 349 | 342 | 32 | 304 | 681 | 626 |
| EPS in Rs | 13.63 | 19.41 | 21.11 | 21.14 | 19.55 | 18.25 | 25.4 | 38.71 | 37.9 | 3.53 | 33.74 | 75.47 | 69.41 |
| Div. Payout % | 18% | 21% | 19% | 19% | 20% | 22% | 20% | 16% | 16% | 85% | 27% | 20% | — |
Balance Sheet
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 90 | 90 | 90 | 90 | 90 | 90 | 90 | 90 | 90 | 90 | 90 | 90 |
| Reserves | 564 | 715 | 870 | 1,045 | 1,194 | 1,313 | 1,524 | 1,822 | 2,142 | 2,147 | 2,410 | 3,046 |
| Borrowings | 38 | 2 | 0 | 170 | 0 | 0 | 81 | 47 | 3 | 18 | 8 | 0 |
| Other Liabilities | 354 | 522 | 686 | 914 | 914 | 940 | 1,163 | 1,779 | 2,108 | 1,773 | 2,205 | 2,620 |
| Total Liabilities | 1,047 | 1,329 | 1,646 | 2,219 | 2,198 | 2,343 | 2,858 | 3,738 | 4,343 | 4,028 | 4,713 | 5,757 |
| Fixed Assets | 88 | 130 | 210 | 226 | 372 | 416 | 544 | 592 | 668 | 708 | 750 | 989 |
| CWIP | 149 | 210 | 232 | 360 | 220 | 161 | 131 | 212 | 204 | 283 | 291 | 247 |
| Investments | 95 | 90 | 61 | 22 | 212 | 116 | 83 | 134 | 32 | 159 | 294 | 361 |
| Other Assets | 715 | 899 | 1,143 | 1,611 | 1,394 | 1,650 | 2,099 | 2,800 | 3,439 | 2,878 | 3,377 | 4,159 |
| Total Assets | 1,047 | 1,329 | 1,646 | 2,219 | 2,198 | 2,343 | 2,858 | 3,738 | 4,343 | 4,028 | 4,713 | 5,757 |
Cash Flow
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 46 | 197 | 181 | 17 | 556 | 146 | 246 | 267 | 328 | 341 | 604 | 656 |
| Investing | -19 | -113 | -104 | -160 | -351 | -59 | -282 | -205 | -112 | -393 | -496 | -445 |
| Financing | -24 | -89 | -38 | 132 | -215 | -60 | 43 | -91 | -97 | -37 | -68 | -118 |
| Net Cash Flow | 3 | -6 | 40 | -11 | -11 | 27 | 8 | -29 | 120 | -89 | 40 | 93 |
| Free Cash Flow | -34 | 196 | 39 | -185 | 413 | -30 | 15 | 33 | 84 | 69 | 211 | 158 |
| CFO/OP | 58 | 95 | 73 | 27 | 169 | 60 | 68 | 49 | 60 | 129 | 103 | 68 |
Ratios
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 156 | 185 | 175 | 191 | 148 | 180 | 177 | 157 | 165 | 173 | 165 | 166 |
| Inventory Days | 72 | 74 | 117 | 169 | 96 | 100 | 117 | 130 | 145 | 155 | 117 | 121 |
| Days Payable | 117 | 179 | 186 | 202 | 167 | 180 | 180 | 172 | 176 | 144 | 158 | 162 |
| Cash Conversion Cycle | 111 | 81 | 106 | 158 | 77 | 100 | 114 | 115 | 134 | 184 | 124 | 125 |
| Working Capital Days | 82 | 95 | 99 | 94 | 71 | 101 | 94 | 88 | 97 | 128 | 92 | 102 |
| ROCE % | 27% | 36% | 32% | 27% | 23% | 18% | 21% | 26% | 21% | 4% | 16% | 30% |
Documents
Frequently Asked Questions about Sharda Cropchem Ltd
What does Sharda Cropchem Ltd do?
Where is Sharda Cropchem Ltd (SHARDACROP) listed?
Which sector does Sharda Cropchem Ltd belong to?
What is the market capitalisation of Sharda Cropchem Ltd?
What is the PE ratio of Sharda Cropchem Ltd?
What is the 52-week high and low of Sharda Cropchem Ltd?
Does Sharda Cropchem Ltd pay dividends?
What is the Return on Equity (ROE) of Sharda Cropchem Ltd?
How can I research Sharda Cropchem Ltd on Tapetide?
Company Information
Sharda Cropchem is principally engaged in export of agrochemicals (technical grade and formulations) and non-agro products such as conveyor belts, rubber belts/sheets, dyes and dye intermediates to various countries across the world.